Here, we show that co-expansion of CD4+CD25hiFoxP3+ T cells and/or tumor cell produced IDO and galectin-3 during MLTC have a negative impact on the activation and expansion of tumor-specific T cells, and we describe different manners to circumvent this. Here, IDO1 is linked to neoplasm.